Free Trial

Nusatrip (NASDAQ:NUTR) Trading Down 0.4% - What's Next?

Nusatrip logo with background
Image from MarketBeat Media, LLC.

Key Points

  • NUSATRIP (NASDAQ:NUTR) shares slid about 0.4% to a last trade of $9.00 after touching $8.65, with roughly 901,200 shares traded; the 50-day moving average is $9.00 and the 200-day moving average is $8.86.
  • The stock carries a consensus Sell rating, with Weiss Ratings recently restating a "sell (e)" recommendation.
  • Several institutional investors have recently initiated or increased positions—including JPMorgan Chase, Citadel Advisors, Squarepoint Ops, Scientech Research—and Jump Financial raised its stake to 21,400 shares (about $193,000).
  • Interested in Nusatrip? Here are five stocks we like better.

Nusatrip Incorporated (NASDAQ:NUTR - Get Free Report)'s stock price fell 0.4% during trading on Thursday . The company traded as low as $8.65 and last traded at $9.00. 901,200 shares were traded during mid-day trading, The stock had previously closed at $9.04.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings restated a "sell (e)" rating on shares of Nusatrip in a report on Monday, December 29th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company has a consensus rating of "Sell".

Read Our Latest Stock Analysis on Nusatrip

Nusatrip Price Performance

The firm's 50-day moving average is $9.00 and its 200-day moving average is $8.86.

Institutional Trading of Nusatrip

Hedge funds have recently bought and sold shares of the business. JPMorgan Chase & Co. acquired a new stake in Nusatrip in the 3rd quarter valued at $25,000. Citadel Advisors LLC bought a new stake in Nusatrip during the 3rd quarter worth approximately $126,000. Jump Financial LLC increased its holdings in Nusatrip by 10.3% during the 4th quarter. Jump Financial LLC now owns 21,400 shares of the company's stock worth $193,000 after purchasing an additional 2,000 shares in the last quarter. Squarepoint Ops LLC bought a new position in shares of Nusatrip in the third quarter valued at approximately $179,000. Finally, Scientech Research LLC bought a new position in shares of Nusatrip in the third quarter valued at approximately $180,000.

About Nusatrip

(Get Free Report)

Nutraceutical International Corporation is an integrated manufacturer, marketer, distributor and retailer of nutritional supplements and other natural products. The Company's products include vitamins and minerals; herbs; specialty formulas; personal care products; liquid nutritional products; homeopathics; functional foods, and other products. It offers its products to and through domestic health and natural food stores. It acts as a distributor to the Healthy Foods Channel and to certain international markets for certain third-party brands.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Nusatrip Right Now?

Before you consider Nusatrip, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nusatrip wasn't on the list.

While Nusatrip currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Click the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines